52 research outputs found

    Effects of aspirin and clopidogrel on neural stem cells

    No full text
    Cerebral infarction causes severe morbidity and mortality. Most patients with cerebral infarction should take antiplatelet drugs daily, so the effects of those drugs on the regeneration of the brain need to be investigated. Aspirin and clopidogrel are the most widely used antiplatelet drugs for the prevention of ischemic stroke. We investigated the effects of aspirin and clopidogrel on neural stem cells (NSCs). NSCs were dissociated from fetal rat cortex and cultured with basic fibroblast growth factor and N2 medium. To measure the effects of aspirin and clopidogrel on NSCs, NSCs were treated with several concentrations of aspirin, clopidogrel bisulfate, and clopidogrel resinate for 24 h. After the treatment, we measured cell viability by cell counting kit-8, MIT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay, trypan blue staining, flow cytometry, and lactate dehydrogenase assay. To evaluate their effects on NSC proliferation, we performed BrdU cell proliferation assay and colonyforming unit assay. We compared the intracellular protein level in the NSCs treated with aspirin and two types of clopidogrel, by proteomics analysis. Various viability tests showed that clopidogrel resinate and clopidogrel bisulfate did not affect the viability and proliferation of NSCs whereas aspirin decreased them even at low concentrations which are clinically relevant. Moreover, through the proteomics, it was confirmed that the toxicity of aspirin to NSCs might be associated with the alteration of several intracellular proteins. Taken together, these results suggest that clopidogrel resinate and clopidogrel bisulfate are safe but aspirin could be toxic to NSCs. Therefore, when these antiplatelet agents are prescribed over the long-term, the finding that aspirin could be toxic to NSCs should be considered.This work was supported by the Basic Science Research Program of the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning (2015R1A2A2A04004865), by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI17C2160), and by Korea Drug Development Fund (KDDF) funded by Ministry of Science and ICT, Ministry of Trade, Industry & Energy and Ministry of Health & Welfare (KDDF-201609-02, Republic of Korea)

    Characteristics of the electron beam from SAFE microcolumn system

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๋ฌผ๋ฆฌํ•™๊ณผ,1996.Maste

    ๋น„์˜ˆํ˜ผํ•ฉ ์™€ํ™˜์—์„œ์˜ ํ™”์—ผ ์ „ํŒŒ์— ๊ด€ํ•œ ์‹คํ—˜์  ์—ฐ๊ตฌ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๊ธฐ๊ณ„๊ณตํ•™๊ณผ,1998.Maste

    An Empirical Study on Training Transfer of the Civil Servants in Korea Local Government

    No full text
    ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ๊ต์œกํ›ˆ๋ จ ์ „์ด์— ์˜ํ–ฅ์˜ฌ ๋ฏธ์น˜๋Š” ์ œ ์š”์ธ๋“ค์„ ๊ตญ๋‚ด ยท ์™ธ ์„ ํ–‰์—ฐ ๊ตฌ์˜ ๋ฌธํ—Œ๊ฒ€ํ† ๋ฅผ ํ†ตํ•ด ๋„์ถœํ•˜์—ฌ ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๋ฌด์›๋“ค์„ ๋Œ€์ƒ์œผ๋กœ ์‹ค์ฆ์ ์œผ ๋กœ ๊ทœ๋ช…ํ•˜์˜€๋‹ค. ์„ ํ–‰์—ฐ๊ตฌ ๊ฒ€ํ†  ๊ฒฐ๊ณผ ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ๊ต์œกํ›ˆ๋ จ ์ „์ด์— ์˜ํ–ฅ์„ ๋ฏธ์น˜ ๋Š” ์ œ ์š”์ธ๋“ค๋กœ ํฌ๊ฒŒ ๋‘ ๊ฐ€์ง€ ์š”์ธ๏ผŒ์ฆ‰ ๊ต์œกํ›ˆ๋ จ ํ”„๋กœ๊ทธ๋žจ์˜ ์„ค๊ณ„์š”์ธ์œผ๋กœ์„œ ๊ฐ• ์‚ฌ์˜ ์ž์งˆ๏ผŒ๊ต์œก๋‚ด์šฉ๏ผŒํ”ผํ›ˆ๋ จ์ž์˜ ๊ฐœ์ธ์  ํŠน์„ฑ(ํ•™์Šต๋™๊ธฐ๏ผŒ์„ฑ์ทจ์š•๊ตฌ๏ผŒ์ž๊ธฐ์œ ๋Šฅ๊ฐ)๊ณผ ์กฐ์ง์  ํ™˜๊ฒฝ์š”์ธ์œผ๋กœ ์ƒ์‚ฌ ๋ฐ ๋™๋ฃŒ์˜ ์ง€์›๏ผŒ์ง€์†์  ํ•™์Šต๋ฌธํ™”๋กœ ์„ค์ •ํ•œ ๋’ค๏ผŒ์„ค๋ฌธ ์กฐ์‚ฌ๋ฅผ ์‹ค์‹œํ•˜์˜€๊ณ  ์กฐ์‚ฌ๊ฒฐ๊ณผ๋ฅผ ์š”์ธ๋ถ„์„๊ณผ ํšŒ๊ท€๋ถ„์„์„ ํ†ตํ•ด ๋ถ„์„ํ•˜์˜€๋‹ค. ๋ถ„์„๊ฒฐ๊ณผ๏ผŒ๊ต์œกํ›ˆ๋ จ ํ”„๋กœ๊ทธํ–„์˜ ์„ค๊ณ„์š”์ธ๊ณผ ์กฐ์ง์  ํ™˜๊ฒฝ์š”์ธ์ด ๊ณต๋ฌด์› ๊ต์œกํ›ˆ ๋ จ ์ „์ด์— ๋Œ€ํ•ด ํ†ต๊ณ„์ ์œผ๋กœ ์œ ์˜๋ฏธํ•œ ๊ธ์ •์ ์ธ ์˜ํ–ฅ์„ ๋ฏธ์นœ๋‹ค๋Š” ๊ฒฐ๋ก ์„ ์–ป์—ˆ๋‹ค
    • โ€ฆ
    corecore